PRICE T ROWE ASSOCIATES INC /MD/ - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 57 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$3,521,000
-26.7%
647,174
-59.5%
0.00%
-100.0%
Q3 2019$4,806,000
-27.1%
1,596,569
-9.4%
0.00%0.0%
Q2 2019$6,591,000
-16.6%
1,762,248
-10.4%
0.00%0.0%
Q1 2019$7,903,000
+8.4%
1,966,042
-1.0%
0.00%0.0%
Q4 2018$7,289,000
-57.3%
1,986,163
-0.1%
0.00%
-50.0%
Q3 2018$17,059,000
-22.3%
1,988,173
-0.6%
0.00%
-33.3%
Q2 2018$21,961,000
-5.0%
2,000,099
-0.2%
0.00%
-25.0%
Q1 2018$23,114,000
+628.7%
2,004,675
+554.7%
0.00%
+300.0%
Q4 2017$3,172,000
-34.9%
306,216
+0.1%
0.00%0.0%
Q3 2017$4,876,000
+16.9%
305,916
-11.2%
0.00%0.0%
Q2 2017$4,170,000
-74.8%
344,601
-56.7%
0.00%
-66.7%
Q1 2017$16,520,000
+88.6%
795,396
+29.8%
0.00%
+50.0%
Q4 2016$8,760,000
-16.6%
612,577
-4.0%
0.00%0.0%
Q3 2016$10,500,000
+19.3%
638,297
+0.5%
0.00%0.0%
Q2 2016$8,799,000
-1.7%
634,888
-0.0%
0.00%0.0%
Q1 2016$8,949,000634,9880.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$11,661,0002.42%
Telemetry Investments, L.L.C. 189,081$673,0001.14%
CHI Advisors LLC 490,877$1,748,0000.49%
BVF INC/IL 1,943,712$6,920,0000.27%
Orbimed Advisors 6,767,584$24,093,0000.21%
Novo Holdings A/S 847,906$3,019,0000.13%
Golden Green, Inc. 19,539$70,0000.06%
ALGERT GLOBAL LLC 15,467$55,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,700$476,0000.01%
Hikari Power Ltd 19,959$71,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders